GLUE (Monte Rosa Therapeutics Inc) Bathi saben saham sajrone patang kuartal pungkasan

The price action of Monte Rosa Therapeutics (GLUE) reflects EPS figures at -599.30. The firm's financial stability is supported by substantial payments from Roche. A proprietary protein degradation method for creating global products provides high growth potential. However, the company is currently spending all its capital on early-stage testing, meaning market pricing for the drugs will only be possible after their efficacy is confirmed.

GLUE Bathi saben saham sajrone rolas wulan pungkasan monterosatx.com (11.02.2024 - 11.11.2026)

Monte Rosa Tx - rincian analitis lan metrik utama (GLUE)

- rega saiki lan proyeksi nilai saham:

Bagan owah-owahan rega monterosatx.com|GLUE - Target konsensus

- indikator valuasi pasar bisnis:

Nilai pasar Monte Rosa Therapeutics Inc|GLUE - Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Monte Rosa Therapeutics|GLUE - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku monterosatx.com|GLUE - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Utang marang Modal Monte Rosa Therapeutics|GLUE - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Monte Rosa Corp|GLUE - Gunggung utang perusahaan|Utang marang modal buku Monte Rosa Therapeutics Inc|GLUE - Utang jangka dawa perusahaan|Utang jangka cendhak Monte Rosa Therapeutics|Rasio likuiditas darurat monterosatx.com

- data bathi lan kelipatan valuasi:

GLUE - Penghasilan resik|Penghasilan resik sing dikarepake Monte Rosa Therapeutics|GLUE - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Monte Rosa Therapeutics Inc|GLUE - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Monte Rosa Therapeutics Inc|GLUE - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Monte Rosa Therapeutics|GLUE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan monterosatx.com|GLUE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Monte Rosa Therapeutics

Pambiji fundamental:monterosatx.com (GLUE)

Produk mawa merek Monte Rosa Therapeutics, Inc.

The market assesses Monte Rosa Therapeutics (GLUE) as a high-risk asset with potential for breakthrough growth. This metric measures the trailing twelve months (TTM) earnings per share dynamics, updating the consensus daily to identify hidden trend reversals. By analyzing the annual growth trend of TTM net income per share, investors align financial expectations with the successes of the protein degradation platform. This biotech startup is classified as a speculative security.

Analisis pesaing Monte Rosa Therapeutics